Mesh Type in Ventral Hernia Repair
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mike Liang, M.D.
- Phone Number: 713-566-5095
- Email: Mike.K.Liang@uth.tmc.edu
Study Contact Backup
- Name: Debbie F Lew, M.P.H.
- Phone Number: 713-566-5097
- Email: Debbie.F.Lew@uth.tmc.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77026
- UT Health at Lyndon B. Johnson General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient scheduled for open ventral hernia repair at LBJ General Hospital
Exclusion Criteria:
- Active infection
- Patient unlikely to survive with the next 2 years based upon surgeon judgment (i.e. metastatic cancer, end-stage cirrhosis)
- Patient surgeon would not normally place a prosthetic (e.g. planned second surgery such as ostomy takedown)
- Patient unlikely to follow-up (i.e. no phone)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Synthetic Mesh
Synthetic mesh (mid-density polypropylene (generic) Bard soft mesh) will be used in open ventral hernia repair
|
Synthetic mesh used during open ventral hernia repair
|
|
Active Comparator: Biologic Mesh
Biologic mesh (non cross linked porcine acellular dermal matrix: Strattice) will be used in open ventral hernia repair
|
Biologic mesh used during open ventral hernia repair
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complication free at 1 year post-operative
Time Frame: 1 year after surgery
|
Complication defined as hernia recurrence, chronic wound complications including mesh infection, and reoperation
|
1 year after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complication free at 3 years post-operative
Time Frame: 3 years after surgery
|
Complication defined as hernia recurrence, chronic wound complications including mesh infection, and reoperation
|
3 years after surgery
|
|
Dindo-clavien complications
Time Frame: Pre-operative, 1 month after surgery, 1 year and 3 years after surgery
|
Grade I to V
|
Pre-operative, 1 month after surgery, 1 year and 3 years after surgery
|
|
Patient centered outcomes
Time Frame: Pre-operative, 1 month after surgery, 1 year and 3 years after surgery
|
includes patient satisfaction, cosmetic satisfaction, modified assessment scale
|
Pre-operative, 1 month after surgery, 1 year and 3 years after surgery
|
|
Cost
Time Frame: 1 year and 3 years after surgery
|
charges for all patient visits, admissions, and procedures
|
1 year and 3 years after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Julie L Holihan, M.D., UT Health
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HSC-MS-16-0936
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.